Sharp Clinical Launches Direct-to-Patient Service With New Partnerships
|Update : 1st July, 2020|
Sharp Clinical Services, part of UDG Healthcare and a leading provider of global clinical supply services, has signed a central pharmacy partnership deal and developed a holistic patient support programme with its sister company, Ashfield.
The company has signed a partnership agreement with European central pharmacy Hubertus, Germany, which will support Sharp’s direct-to-patient logistics service for its clinical trial clients in Europe and neighboring nations.
The partnership will further enable Sharp to respond to the increasing demand for distribution direct-to-patients’ homes as part of virtual and hybrid trials which are expected to become the norm in the near future. It’s the second such agreement for Sharp, which has a similar partnership in place in the US. The agreement with Hubertus means Sharp now has the foundation to offer direct-to-patient services in the two largest markets in the world.
Sascha Sonnenberg, Global Head of Business Development, Sharp Clinical Services, said, “I’m excited to see how we have successfully worked together with our partners and colleagues to establish a comprehensive solution to the benefit of our clients and patients participating in clinical trials. This is not just a temporary option during the COVID-19 situation, but will experience an increasing demand in a post-pandemic era.”
Sharp has also joined forces with the Patient Solutions business unit of its sister company, Ashfield. The service will provide clinical educator-led ministering in key areas such as injection training, infusions and blood pressure monitoring to patients in their own home.
This service can be delivered either through in-person visits in Europe or remotely in both the US and Europe as part of a holistic and compliant solution for clinical trial sponsors.
Sascha added, “The breadth and depth of this solution is a unique offering to sponsors in the clinical services market. We can now provide a holistic solution – delivering drugs directly to trial participants as well as supporting them throughout their participation.”
Sharp, part of UDG healthcare, is a global leader in contract packaging and clinical services. Operating from eight state-of-the-art facilities across the US and Europe, Sharp has built an international reputation for delivering cost-effective blister packaging, bottling, secondary assembly and labelling of injectable presentations, compliance packaging, formulation and manufacturing services, label design and printing. Sharp is also a world leader in ’Track and Trace’ and serialization services, with over 11 years’ experience in implementing serialized solutions for its pharma clients.
Sharp Clinical offers a full complement of clinical trial services, including analytical, formulation development, clinical manufacturing and packaging, storage and distribution. Sharp also offers an interactive response technology (IRT) platform which can accommodate simple to complex randomization schemes as well as clinical supply chain management.
During 2018, Sharp Clinical invested $36 million in new dedicated facilities in both the US and the UK and can offer QP services for European distribution. We service every phase of the drug lifecycle from Phase 1 through to commercialization and through our global network of over 30 depots we can distribute to every region of the world. Our highly experienced team will help you optimize every aspect of your clinical trial.
For further information, images and interview opportunities with Sharp, please contact Matthew Dent at ramarketing |firstname.lastname@example.org | +34 711 00 80 99 |
Marketing Communications Manager
Source : Sharp Clinical